Business News

Persistent acknowledged as a 'Most Honored Company' in Extel's 2025 Asia (ex-Mainland China) Executive Team survey

Persistent Achieves Top Rankings for the Second Year in a Row in Extel's Asia Executive Team Survey

Jun 05, 2025

Servier India introduces 'Ivosidenib'(Tibsovo®), in India, First-in-class Targeted Therapy in Oncology for Rare IDH1-Mutated AML and Cholangiocarcinoma

Servier India introduces 'Ivosidenib'(Tibsovo®), in India, First-in-class Targeted Therapy in Oncology for Rare IDH1-Mutated AML and Cholangiocarcinoma

Jun 05, 2025

SSODL's hands-on learning bridges theory & practice, preparing you for today's careers with confidence.

Navigating the New Age Job Market with SSODL's Practical Learning Approach

Jun 05, 2025

More News